SCHEMBL18563010

SCHEMBL18563010

O=c1oc2ccccc2cc1N1CC(c2ccccc2)N=N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ MAOB P27338 2/20 0.44
▸ TERT O14746 6/20 0.42
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA3 P07451 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ GPR35 Q9HC97 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ TYR P14679 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11881753 0.73 RAB9A (0.45) RAB9AKDM4EALDH1A1MAOBCA12
SCHEMBL17144366 0.67 HSD17B10 (0.55) RAB9AKDM4EALDH1A1MAOBCA12
SCHEMBL29044069 0.67 HPGD (0.50) RAB9AKDM4EALDH1A1MAOBCA12
SCHEMBL15068474 0.67 HPGD (0.43) RAB9AKDM4EALDH1A1MAOBCA12
SCHEMBL15068569 0.67 KDM4E (0.43) RAB9AKDM4EALDH1A1MAOBCA12
SCHEMBL21524868 0.67 HRH4 (0.45) RAB9AKDM4EALDH1A1MAOBCA12
SCHEMBL5867498 0.66 MAOA (0.56) RAB9AKDM4EALDH1A1MAOBSMN1; SMN2
SCHEMBL31004956 0.65 HPGD (0.47) RAB9AKDM4EALDH1A1MAOBCA12
SCHEMBL722215 0.65 BACE1 (0.55) RAB9AKDM4EALDH1A1MAOBTSHR
SCHEMBL16669677 0.65 KDM4E (0.41) RAB9AKDM4EALDH1A1MAOBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10851407-B2 Left-handed gamma-peptide nucleic acids, methods of synthesis and uses therefor CARNEGIE MELLON UNIVERSITY (US) 2020-12-01 — — US disclosed
US-20170058325-A1 Left-Handed Gamma-Peptide Nucleic Acids, Methods of Synthesis and Uses Therefor CARNEGIE MELLON UNIVERSITY 2017-03-02 — — US disclosed
US-20170058325-A1 Left-Handed Gamma-Peptide Nucleic Acids, Methods of Synthesis and Uses Therefor CARNEGIE MELLON UNIVERSITY 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10851407-B2 Left-handed gamma-peptide nucleic acids, methods of synthesis and uses therefor NPPA, POLL, POLI RAB9A 4096/4885KDM4E 4837/4885ALDH1A1 4092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback